The Clorox Company (NYSE:CLX – Get Rating) – Analysts at DA Davidson dropped their FY2023 earnings estimates for Clorox in a research report issued on Wednesday, May 4th. DA Davidson analyst L. Weiser now anticipates that the company will post earnings per share of $5.66 for the year, down from their previous estimate of $6.43.
Clorox (NYSE:CLX – Get Rating) last announced its quarterly earnings results on Monday, May 2nd. The company reported $1.31 EPS for the quarter, beating the consensus estimate of $0.97 by $0.34. Clorox had a return on equity of 92.98% and a net margin of 6.44%. During the same period in the previous year, the business posted $1.62 earnings per share.
Clorox stock traded up $0.35 during mid-day trading on Friday, hitting $148.62. 5,835 shares of the company were exchanged, compared to its average volume of 1,333,241. The company has a quick ratio of 0.36, a current ratio of 0.71 and a debt-to-equity ratio of 3.28. The business has a fifty day moving average of $141.88 and a 200 day moving average of $157.47. Clorox has a 1-year low of $127.02 and a 1-year high of $191.75. The company has a market capitalization of $18.26 billion, a PE ratio of 40.18, a price-to-earnings-growth ratio of 5.06 and a beta of 0.18.
Several hedge funds have recently modified their holdings of the company. Xponance Inc. grew its position in Clorox by 9.5% in the fourth quarter. Xponance Inc. now owns 18,036 shares of the company’s stock worth $3,145,000 after acquiring an additional 1,568 shares during the period. Wealthfront Advisers LLC grew its holdings in shares of Clorox by 18.3% during the fourth quarter. Wealthfront Advisers LLC now owns 24,226 shares of the company’s stock worth $4,224,000 after purchasing an additional 3,752 shares during the last quarter. Gofen & Glossberg LLC IL grew its holdings in shares of Clorox by 19.9% during the fourth quarter. Gofen & Glossberg LLC IL now owns 5,885 shares of the company’s stock worth $1,026,000 after buying an additional 977 shares during the last quarter. DNB Asset Management AS grew its holdings in shares of Clorox by 3.8% during the fourth quarter. DNB Asset Management AS now owns 49,549 shares of the company’s stock worth $8,639,000 after buying an additional 1,819 shares during the last quarter. Finally, Pendal Group Ltd lifted its position in Clorox by 259.2% in the fourth quarter. Pendal Group Ltd now owns 4,641 shares of the company’s stock valued at $809,000 after purchasing an additional 3,349 shares during the period. 77.28% of the stock is owned by institutional investors and hedge funds.
The business also recently declared a quarterly dividend, which will be paid on Friday, May 13th. Stockholders of record on Wednesday, April 27th will be issued a $1.16 dividend. The ex-dividend date is Tuesday, April 26th. This represents a $4.64 dividend on an annualized basis and a dividend yield of 3.12%. Clorox’s dividend payout ratio is presently 125.75%.
About Clorox (Get Rating)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States.
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- AMD (NASDAQ: AMD) Shines Green In A Sea Of Red
- Expedia or Bookings Holdings: Which Stock Should You Travel With?
- Is This The Bottom For Papa John’s International?
- Kellogg Company Flexes Pricing Power, Shares Move Higher
- Peak Growth Is Over For Etsy
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.